|
|
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
|
5R01CA116337-04
|
$514,171
|
$514,171
|
RUBIN, MARK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
|
"Statistical Methods for Genetic Epidemiology"
|
5R01CA094069-08
|
$573,074
|
$194,845
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
|
"Strength training, Self-efficacy, and Function in Blacks with Prostate Cancer."
|
5R21CA127784-02
|
$199,964
|
$199,964
|
HURLEY, BERNARD
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
|
|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
5R01CA131445-02
|
$221,524
|
$221,524
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
|
18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma
|
5R01CA129356-03
|
$343,987
|
$343,987
|
Schuster, David
|
EMORY UNIVERSITY
|
|
|
1H MRI based nanosensors for imaging tumor oxygenation
|
1R21CA132096-01A1
|
$172,700
|
$86,350
|
Kodibagkar, Vikram
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
|
3-D Transrectal Ultrasound with 2-D Arrays
|
5R01CA116379-02
|
$248,041
|
$248,041
|
YEN, JESSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-02
|
$393,213
|
$98,303
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
|
A Genome-wide Association Study of Prostate Cancer in African Americans
|
1U01CA136792-01
|
$3,454,975
|
$3,454,975
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A microfluidic platform to study the effects of chemokine gradients on prostate c
|
1R15CA133623-01A1
|
$205,407
|
$205,407
|
CHIAO, JUNG-CHIH
|
UNIVERSITY OF TEXAS ARLINGTON
|
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$109,726
|
$43,891
|
Kelly, Kathleen
|
CCR (NCI)
|
|
|
A Nanotechnology Enabled Point of Care Diagnostic Platform for Early Stage Cancer
|
1R43CA143232-01A1
|
$199,156
|
$199,156
|
Nelson, James
|
INANOVATE, INC.
|
|
|
A New Class of Mechanistic Risk Prediction Models for Cancer Treatment Outcomes
|
5R21CA131603-02
|
$173,250
|
$173,250
|
HUANG, LI-SHAN
|
UNIVERSITY OF ROCHESTER
|
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-05
|
$280,899
|
$280,899
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Novel Synthetic Androgen Receptor Antagonist
|
5R01CA131137-02
|
$323,700
|
$323,700
|
DONG, ZHONGYUN
|
UNIVERSITY OF CINCINNATI
|
|
|
A phase II study of IPI-504 in metastatic hormone refractory prostate cancer
|
5R21CA128352-02
|
$263,979
|
$263,979
|
oh, william
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
1R01CA134493-01A1
|
$745,852
|
$745,852
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Rigid Multivalent Chemical Platform for Targeted Diagnostics and Therapeutics
|
5F32CA132332-02
|
$53,354
|
$53,354
|
Nasr, Khaled
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Role of Novel Serpin Maspinin Prostate Tumor/Bone Interaction
|
5R01CA127735-02
|
$312,288
|
$312,288
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
|
A Serum Marker for Aggressive Prostate Cancer
|
5R01CA121460-04
|
$439,850
|
$439,850
|
PEEHL, DONNA
|
STANFORD UNIVERSITY
|
|
|
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
|
5R01CA126596-03
|
$588,226
|
$147,057
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A trial-based MISCAN model for prostate cancer
|
3U01CA115996-04S1
|
$105,209
|
$105,209
|
DE KONING, HARRY
|
ERASMUS MEDICAL CENTER
|
|
|
A2a receptor engagement promotes T cell tolerance
|
5R01CA114227-04
|
$273,392
|
$273,392
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$3,404
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$2,970
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$217,601
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
5R01CA133148-02
|
$462,824
|
$115,706
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
|
Accuracy of Physical Activity Measures in Cancer Studies
|
5R01CA103974-05
|
$352,092
|
$176,046
|
STERNFELD, BARBARA
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
|
Acoustic Radiation Force Imaging of Colorectal Tissues
|
5R01CA114075-05
|
$282,727
|
$141,364
|
NIGHTINGALE, KATHRYN
|
DUKE UNIVERSITY
|
|
|
Activation of the Cancer Preventive Nrf2-ARE Pathway by Seaweed
|
5R21CA133681-02
|
$156,541
|
$78,271
|
LUESCH, HENDRIK
|
UNIVERSITY OF FLORIDA
|
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$9,751,832
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
|
Adiposity and Outcomes of Clinically Localized Prostate Cancer
|
1R01CA129140-01A2
|
$660,462
|
$660,462
|
Freeman, Vincent
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-05
|
$245,369
|
$245,369
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
|
5R01CA123194-03
|
$454,956
|
$454,956
|
Sillerud, Laurel
|
UNIVERSITY OF NEW MEXICO
|
|
|
Alpha Methyl AcylCoa Racemase (AMACR)
|
1R21CA131702-01A2
|
$216,480
|
$216,480
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors
|
1R01CA127727-01A2
|
$323,700
|
$323,700
|
Garcia-Blanco, Mariano
|
DUKE UNIVERSITY
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$1,112,049
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
An androgen receptor coactivator regulated in prostate
|
5R01CA112226-02
|
$351,713
|
$351,713
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
An Interactive Video Doctor to Encourage Cancer Screening
|
5R21CA127834-02
|
$139,284
|
$34,821
|
WALSH, JUDITH
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Analyses of human T regulatory cells
|
ZIA BC 010973
|
$283,284
|
$84,985
|
Tsang, Kwong
|
CCR (NCI)
|
|
|
Analysis of Homing Receptors in Prostate Cancer
|
5R01CA118124-03
|
$282,720
|
$282,720
|
DIMITROFF, CHARLES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
|
ZIA BC 010425
|
$396,900
|
$158,760
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
|
Analysis of Lag-3 in Regulatory T Cell Function and Immune Supression
|
5R01CA127153-02
|
$340,300
|
$340,300
|
DRAKE, CHARLES
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Analysis of the STAT3 Pathway In Tumor Tolerance and Immune Evasion
|
5R01CA125192-04
|
$282,659
|
$197,861
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer
|
5R01CA127873-02
|
$281,066
|
$281,066
|
SHEMSHEDINI, LIRIM
|
UNIVERSITY OF TOLEDO
|
|
|
Androgen Receptor Function in Prostate Cancer
|
2R01CA086072-07A2
|
$320,588
|
$320,588
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Androgen Receptor Regulation by Phosphorylation
|
5K99CA135592-02
|
$97,295
|
$97,295
|
Chen, Shaoyong
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
ANDROGEN RECEPTOR SIGNALING IN SELENIUM CHEMOPREVENTION
|
5K01CA114252-05
|
$153,662
|
$153,662
|
DONG, YAN
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Androgen signaling and kinase regulation in PCA
|
5R01CA114575-05
|
$224,441
|
$224,441
|
Kung, Hsing-Jien
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
Androgenic Inactivation of FOXO1 in Prostate Cancer
|
5R01CA125747-07
|
$263,376
|
$263,376
|
TINDALL, DONALD
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Total relevant funding to Prostate for this search: $293,932,674
|
